Showing results (301-310 of 561) with videos related to
Sort By:
Pageof 57
Cancer Research|October 30, 2003
Molecular pharmacology of cancer therapy in human colorectal cancer by gene expression profilingPaul A Clarke, Mark L George, Sandra Easdale, et al.AJR. American Journal of Roentgenology|October 24, 2006
Potential of surface-coil MRI for staging of esophageal cancerAngela M Riddell, Julia Hillier, Gina Brown, et al.Leukemia & Lymphoma|November 5, 2021
Risk of thyroid disorders in adult and childhood Hodgkin lymphoma survivors 40 years after treatmentAislinn Macklin-Doherty, Michael Jones, Penny Coulson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2022
Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction AdenocarcinomaManish A Shah, Kohei Shitara, Florian Lordick, et al.JCO Global Oncology|January 23, 2025
Precision Oncology: A Global Perspective on Implementation and Policy DevelopmentDenis Horgan, Marcel Tanner, Charu Aggarwal, et al.Annals of Surgery|September 14, 2021
Prognostic Significance of Negative Lymph Node Long Axis in Esophageal Cancer: Results From the Randomized Controlled UK MRC OE02 TrialMaximilian Kloft, Jessica E Ruisch, Gayatri Raghuram, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2004
A randomized trial comparing defined-duration with continuous irinotecan until disease progression in fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancerRohit Lal, James Dickson, David Cunningham, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2002
Multicenter randomized phase III trial comparing protracted venous infusion (PVI) fluorouracil (5-FU) with PVI 5-FU plus mitomycin in inoperable pancreatic cancerNick Maisey, Ian Chau, David Cunningham, et al.Mammalian Genome : Official Journal of the International Mammalian Genome Society|April 17, 2002
exma: an X-linked insertional mutation that disrupts forebrain and eye developmentDavid Cunningham, Qiang Xiao, Aurobindo Chatterjee, et al.Surgery|May 27, 2018
A Cost-Effectiveness Analysis of a Pediatric Operating Room in UgandaAva Yap, Arlene Muzira, Maija Cheung, et al.Pageof 57